Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (191-200 of 261) with videos related to

Pageof 27
Sort By:
The Journal of Infection|August 17, 2021
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, EnglandShamez N Ladhani, Georgina Ireland, Frances Baawuah, et al.
International Journal of Epidemiology|March 5, 2016
Cohort Profile: The Flu Watch StudyEllen B Fragaszy, Charlotte Warren-Gash, Lili Wang, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 20, 2020
Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in EnglandMark Joy, Fd Richard Hobbs, Jamie Lopez Bernal, et al.
Eclinicalmedicine|March 2, 2022
Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, EnglandShamez N Ladhani, Georgina Ireland, Frances Baawuah, et al.
The Journal of Infection|January 16, 2023
Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18  influenza seasonsMark Reacher, Ben Warne, Neville Q Verlander, et al.
Vaccine|November 6, 2019
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard G Pebody, Heather Whitaker, Joanna Ellis, et al.
Lancet (London, England)|April 12, 2021
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)Victoria Jane Hall, Sarah Foulkes, Andre Charlett, et al.
Journal of Virology|May 17, 2013
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study GroupRaoul J de Groot, Susan C Baker, Ralph S Baric, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2019
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18Richard Pebody, Abdelmajid Djennad, Joanna Ellis, et al.
JCI Insight|April 14, 2017
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenzaSuzanne L Cole, Jake Dunning, Wai Ling Kok, et al.
Pageof 27

Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Infection|August 17, 2021
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, EnglandShamez N Ladhani, Georgina Ireland, Frances Baawuah, et al.
International Journal of Epidemiology|March 5, 2016
Cohort Profile: The Flu Watch StudyEllen B Fragaszy, Charlotte Warren-Gash, Lili Wang, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 20, 2020
Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in EnglandMark Joy, Fd Richard Hobbs, Jamie Lopez Bernal, et al.
Eclinicalmedicine|March 2, 2022
Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, EnglandShamez N Ladhani, Georgina Ireland, Frances Baawuah, et al.
The Journal of Infection|January 16, 2023
Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18  influenza seasonsMark Reacher, Ben Warne, Neville Q Verlander, et al.
Vaccine|November 6, 2019
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard G Pebody, Heather Whitaker, Joanna Ellis, et al.
Lancet (London, England)|April 12, 2021
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)Victoria Jane Hall, Sarah Foulkes, Andre Charlett, et al.
Journal of Virology|May 17, 2013
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study GroupRaoul J de Groot, Susan C Baker, Ralph S Baric, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 8, 2019
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18Richard Pebody, Abdelmajid Djennad, Joanna Ellis, et al.
JCI Insight|April 14, 2017
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenzaSuzanne L Cole, Jake Dunning, Wai Ling Kok, et al.
Pageof 27